- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Modalis Therapeutics Corp (4883)
Modalis Therapeutics Corp stock price live, this page displays TYO 4883 stock exchange data. View the 4883 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Modalis Therapeutics Corp real time stock price chart below.
What Is the Modalis Therapeutics Corp Stock Price Today?
The Modalis Therapeutics Corp stock price today is 88.0.
What Is the Stock Symbol for Modalis Therapeutics Corp?
The stock symbol for Modalis Therapeutics Corp is ""4883.""
What Stock Exchange Does Modalis Therapeutics Corp Trade On?
Modalis Therapeutics Corp is listed and trades on the Tokyo stock exchange.
Is Modalis Therapeutics Corp a Good Stock to Buy?
Determining whether Modalis Therapeutics Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4883 quote. (ISIN: JP3922600006)
What Is the Modalis Therapeutics Corp Stock Price Today?
The Modalis Therapeutics Corp stock price today is 88.0.
What Is the Stock Symbol for Modalis Therapeutics Corp?
The stock symbol for Modalis Therapeutics Corp is ""4883.""
What Stock Exchange Does Modalis Therapeutics Corp Trade On?
Modalis Therapeutics Corp is listed and trades on the Tokyo stock exchange.
Is Modalis Therapeutics Corp a Good Stock to Buy?
Determining whether Modalis Therapeutics Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4883 quote. (ISIN: JP3922600006)
Tokyo
Currency in JPY
88.0
+2.0(+2.33%)
Closed·
Fair Value
An estimate of a Modalis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
85.0
88.0
52 wk Range
66.0
167.0
4883 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
4883 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Modalis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
85.088.0
52 wk Range
66.0167.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4883 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Modalis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Modalis Therapeutics Corp Company Profile
Modalis Therapeutics Corporation engages in the research and development of therapeutics to treat patients with serious genetic disorders. It is developing therapies for genetic diseases using its proprietary CRISPR-GNDM technology that enables to control gene expressions through modulating the switch (epigenetics of a specific locus. The company has a. joint research agreement with JCR Pharmaceuticals Co., Ltd. to evaluate the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming CNS diseases as a target; and a strategic collaboration with SOLVE FSHD to develop an innovative therapy for facioscapulohumeral muscular dystrophy, a debilitating muscular disorder. The company was formerly known as EdiGENE Corporation and changed its name to Modalis Therapeutics Corporation in August 2019. Modalis Therapeutics Corporation was founded in 2016 and is headquartered in Tokyo, Japan.
Compare 4883 to Peers and Sector
Metrics to compare | 4883 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4883PeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.3x | −8.9x | −0.6x | |
PEG Ratio | −0.07 | 0.04 | 0.00 | |
Price/Book | 2.1x | 7.9x | 2.6x | |
Price / LTM Sales | - | 45.1x | 3.3x | |
Upside (Analyst Target) | - | 61.8% | 39.0% | |
Fair Value Upside | Unlock | 5.9% | 4.9% | Unlock |
Earnings
Latest Release
Aug 07, 2025
EPS / Forecast
-4.76 / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Modalis Trade On?
Modalis is listed and trades on the Tokyo Stock Exchange stock exchange.
What Is the Stock Symbol for Modalis?
The stock symbol for Modalis is "4883."
What Is the Modalis Market Cap?
As of today, Modalis market cap is 6.85B.
What Is Modalis's Earnings Per Share (TTM)?
The Modalis EPS (TTM) is -23.81.
When Is the Next Modalis Earnings Date?
Modalis will release its next earnings report on 05 Nov 2025.
From a Technical Analysis Perspective, Is 4883 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Modalis Stock Split?
Modalis has split 0 times.
How Many Employees Does Modalis Have?
Modalis has 14 employees.
What is the current trading status of Modalis (4883)?
As of 26 Aug 2025, Modalis (4883) is trading at a price of 88.00, with a previous close of 86.00. The stock has fluctuated within a day range of 85.00 to 88.00, while its 52-week range spans from 66.00 to 167.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.